Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Third-Generation Sequencing Technology Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The market size for third-generation sequencing technology has experienced significant expansion recently. Projections indicate it will expand from $14 billion in 2025 to $15.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. This historical increase is primarily due to factors such as genomics research funding, the constraints of short-read sequencing, increased adoption in academic research, the proliferation of rare disease studies, and advancements in technology._x000D_
_x000D_
The third-generation sequencing technology market is set for considerable expansion over the next few years, with projections indicating it will reach $26.71 billion in 2030, growing at a compound annual growth rate (CAGR) of 13.7%. This anticipated rise can be attributed to several factors such as the increasing reach of precision medicine, wider acceptance of clinical diagnostics, ongoing reductions in sequencing costs, enhanced integration with AI analytics, and various population genomics initiatives. Key trends characterizing this forecast period include advancements in long-read sequencing technologies, the development of real-time DNA sequencing, broader clinical genomics adoption, single-molecule sequencing, and the emergence of portable sequencing platforms._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Third-Generation Sequencing Technology Market Demand Drivers Opening New Revenue Streams#_x000D_
The growing acceptance of personalized medicine is anticipated to fuel the expansion of the third-generation sequencing technology market in the future. Personalized medicine defines a medical approach that customizes treatment and prevention plans to align with an individual’s specific genetic makeup, lifestyle, and environmental factors. The increased adoption of personalized medicine is largely driven by advancements in genomics, which enable the precise identification of genetic variations and the development of personalized treatments. Third-generation sequencing technology enhances personalized medicine by providing long-read, high-accuracy genomic data, facilitating the accurate detection of genetic variations. It supports customized treatment strategies by offering comprehensive insights into individual genomes, leading to improved clinical outcomes and the progression of precision healthcare. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. Therefore, the rising adoption of personalized medicine is stimulating the growth of the third-generation sequencing technology market._x000D_
_x000D_
#Third-Generation Sequencing Technology Market Segmentation: How Does The Market Break Down By Category?#_x000D_
The third-generation sequencing technology market covered in this report is segmented – _x000D_
_x000D_
1) By Technology Type: Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing_x000D_
2) By Workflow: Sample Preparation, Sequencing, Data Analysis, Data Interpretation, Data Storage And Management_x000D_
3) By Application: Genomics, Transcriptomics, Epigenomics, Metagenomics, Personalized Medicine, Synthetic Biology_x000D_
4) By End-User: Academic Institutions, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Research Organizations, Government And Non-Profit Organizations_x000D_
_x000D_
Subsegments:_x000D_
1) By Single-Molecule Real-Time Sequencing (SMRT): Zero-Mode Waveguides (ZMWs), Circular Consensus Sequencing (CCS), High-Fidelity (HiFi) Reads_x000D_
2) By Nanopore Sequencing: Portable Nanopore Sequencers, Benchtop Nanopore Sequencers, High-Throughput Nanopore Platforms_x000D_
_x000D_
#Third-Generation Sequencing Technology Market Trends Powering Strategic Industry Growth#_x000D_
Leading companies in the third-generation sequencing technology market are concentrating on creating advanced sequencing platforms, such as ultra-rapid and scalable sequencing systems, with the goal of increasing research efficiency, improving clinical relevance, and decreasing both processing times and expenses. Ultra-rapid and scalable sequencing systems denote inventive technologies that allow high-throughput, real-time genomic analysis with exceptional speed and precision, thus enabling thorough genomic profiling across various applications. For example, in February 2025, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced its Sequencing by Expansion (SBX) technology. This is a fully integrated, next-generation sequencing system that utilizes a patented biochemical method to convert DNA or RNA sequences into quantifiable surrogate polymers called Xpandomers, thereby enabling highly accurate single-molecule nanopore sequencing. The SBX platform incorporates ultra-rapid, scalable sequencing functionalities and automated data analysis, yielding whole-genome sequencing results within hours rather than days, without significant manual involvement._x000D_
_x000D_
#Third-Generation Sequencing Technology Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the third-generation sequencing technology market are Oxford Nanopore Technologies, Pacific Biosciences, Quantapore, Ultima Genomics, BGI Genomics, MGI Tech, Complete Genomics, Stratos Genomics, VisiGen Biotechnologies, Helicos Biosciences, Genia Technologies, Electronic Bio Sciences, Quantum Biosystems, Base4 Innovation, Nabsys, Chronix Biomedical, Roche, Nanopore Diagnostics, GenapSys, SomaLogic _x000D_
_x000D_
#View The Full Third-Generation Sequencing Technology Market Report:#_x000D_
_x000D_
#Third-Generation Sequencing Technology Market Leading Geography: Which Region Contributes The Most Revenue?#_x000D_
North America was the largest region in the third-generation sequencing technology market in 2025. The regions covered in the third-generation sequencing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.